{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:10:11Z","timestamp":1779167411325,"version":"3.51.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Primary aldosteronism (PA) has traditionally been approached as a disorder of anatomical subtype classification, with treatment decisions largely structured around distinction between unilateral and bilateral disease. Although this framework remains essential for therapeutic orientation, it does not fully account for the marked heterogeneity in cardiovascular, renal, and metabolic outcomes observed across patients with PA. Increasing evidence suggests that long-term prognosis in PA reflects not only laterality, but also the cumulative burden of mineralocorticoid receptor activation, current hormonal activity, and interindividual tissue susceptibility. Clinical target-organ damage, persistent renin suppression, magnitude of aldosterone excess, steroidogenic profiles, cortisol co-secretion, and somatic or germline molecular features may each provide complementary information that is not captured by subtype designation alone. In this review, we examine the limitations of a binary anatomical paradigm for risk estimation and summarise emerging evidence supporting a multidimensional framework integrating clinical burden, functional hormonal activity, and molecular context. We further discuss the implications of this framework for treatment adequacy assessment, longitudinal follow-up, and future endpoint-driven research. PA should therefore be considered not only a disorder requiring subtype assignment, but also a stratifiable cardiometabolic condition in which estimation of residual organ risk may be as clinically relevant as determination of anatomical laterality. Prospective validation is still required, but laterality alone appears insufficient for longitudinal risk stratification and treatment adequacy assessment in PA.<\/jats:p>","DOI":"10.3389\/fendo.2026.1842927","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:29Z","timestamp":1779164549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary aldosteronism beyond laterality: integrating subtype assignment with outcome-oriented risk stratification"],"prefix":"10.3389","volume":"17","author":[{"given":"Shida","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Second People\u2019s Hospital of Bengbu City","place":["Bengbu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Children\u2019s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents\u2019 Health and Diseases","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: A position statement and consensus of the working group on endocrine hypertension of the european society of hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: An endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1686480","article-title":"Data-driven cluster analysis and external validation identify phenotypic subgroups in renin-independent aldosteronism with differential cardiovascular risk and therapeutic implications","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023082","article-title":"Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: A collaborative study","volume":"10","author":"Hu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae145","article-title":"The spectrum of dysregulated aldosterone production: An international human physiology study","volume":"109","author":"Parksook","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: A cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-025-02273-1","article-title":"A systematic review to compare adrenalectomy and mineralocorticoid receptor antagonists in patients with unilateral primary aldosteronism","volume":"48","author":"Yoshida","year":"2025","journal-title":"Hypertens Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae683","article-title":"Arterial stiffness associated with long-term major adverse cardiac events in patients with primary aldosteronism","volume":"110","author":"Wu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","article-title":"Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism","volume":"80","author":"Katsuragawa","year":"2023","journal-title":"Hypertension"},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/bs.vh.2025.08.002","article-title":"Clinical manifestations of primary aldosteronism and cardiometabolic risk","volume":"130","author":"Pascual-Corrales","year":"2026","journal-title":"Vitam Horm"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1530\/joe-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002634","article-title":"The role of adrenal venous sampling and computed tomography in the management of primary aldosteronism","volume":"39","author":"Ma","year":"2021","journal-title":"J Hypertens"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2023.11.029","article-title":"Imaging concordance with vein sampling for primary aldosteronism: A cohort study and literature review","volume":"296","author":"Cartwright","year":"2024","journal-title":"J Surg Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000850","article-title":"Diagnostic consistency between computed tomography and adrenal vein sampling of primary aldosteronism: Leading to successful curative outcome after adrenalectomy; a retrospective study","volume":"110","author":"Kim","year":"2024","journal-title":"Int J Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/1754-9485.13573","article-title":"The where, who and how of adrenal vein sampling in Australia and New Zealand","volume":"68","author":"Ng","year":"2024","journal-title":"J Med Imaging Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpad089","article-title":"Intraprocedural cortisol measurement increases adrenal vein cannulation success rate in primary aldosteronism: A systematic review and meta-analysis","volume":"37","author":"Zhou","year":"2024","journal-title":"Am J Hypertens"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac104","article-title":"Effect of intraprocedural cortisol measurement on acth-stimulated adrenal vein sampling in primary aldosteronism","volume":"6","author":"Kometani","year":"2022","journal-title":"J Endocr Soc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12902-020-00591-8","article-title":"Clinical outcomes of primary aldosteronism based on lateralization index and contralateral suppression index after adrenal venous sampling in real-world practice: A retrospective cohort study","volume":"20","author":"Lee","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae142","article-title":"Contralateral suppression in adrenal venous sampling predicts clinical and biochemical outcome in primary aldosteronism","volume":"109","author":"Okubo","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa519","article-title":"Low-grade cortisol cosecretion has limited impact on acth-stimulated avs parameters in primary aldosteronism","volume":"105","author":"O'Toole","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.22281","article-title":"Unilateral primary aldosteronism: Long-term disease recurrence after adrenalectomy","volume":"81","author":"Tetti","year":"2024","journal-title":"Hypertension"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-09692-7","article-title":"Contralateral suppression index does not predict clinical cure in patients undergoing surgery for primary aldosteronism","volume":"28","author":"Dominguez","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102791","article-title":"Global and regional prevalence and cardiovascular risk of primary aldosteronism: A systematic review and meta-analysis","volume":"49","author":"Huang","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.798364","article-title":"Cerebro-cardiovascular risk, target organ damage, and treatment outcomes in primary aldosteronism","volume":"8","author":"Lin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/ejendo\/lvaf271","article-title":"Evaluating the impact of adrenalectomy and mineralocorticoid receptor antagonists for primary aldosteronism on left ventricular remodeling: A systematic review and meta-analysis","volume":"194","author":"Chang","year":"2026","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2025.2565441","article-title":"Elevated plasma aldosterone concentrations relate to renal impairment in chinese southwestern people","volume":"41","author":"Yan","year":"2025","journal-title":"Curr Med Res Opin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1606182","article-title":"Risk factors for renal impairment in primary aldosteronism: A retrospective study","volume":"16","author":"Qin","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14824","article-title":"The association between blood pressure variability and renal damage in patients with primary aldosteronism","volume":"26","author":"Wu","year":"2024","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad520","article-title":"Subtype-specific body composition and metabolic risk in patients with primary aldosteronism","volume":"109","author":"Park","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-00467-3","article-title":"The mineralocorticoid receptor-an emerging player in metabolic syndrome","volume":"35","author":"Thuzar","year":"2021","journal-title":"J Hum Hypertens"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.16498","article-title":"Genetics of primary aldosteronism","volume":"79","author":"Scholl","year":"2022","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169042","article-title":"Clinical translationality of kcnj5 mutation in aldosterone producing adenoma","volume":"23","author":"Kitamoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-21-0031","article-title":"Genetics in endocrinology: Impact of race and sex on genetic causes of aldosterone-producing adenomas","volume":"185","author":"Nanba","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.21037\/gs.2019.10.22","article-title":"Primary aldosteronism diagnostics: Kcnj5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas","volume":"9","author":"Rege","year":"2020","journal-title":"Gland Surg"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1061704","article-title":"Cardiovascular and metabolic characters of kcnj5 somatic mutations in primary aldosteronism","volume":"14","author":"Chang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071041","article-title":"The mineralocorticoid receptor in salt-sensitive hypertension and renal injury","volume":"32","author":"Ayuzawa","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21358","article-title":"Mineralocorticoid receptors in vascular smooth muscle: Blood pressure and beyond","volume":"81","author":"Camarda","year":"2024","journal-title":"Hypertension"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000929","article-title":"Interplay between the mineralocorticoid system, inflammation, hypertension, and kidney disease","volume":"6","author":"Fields","year":"2025","journal-title":"Kidney360"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15708","article-title":"Mineralocorticoid receptor in cardiovascular diseases-clinical trials and mechanistic insights","volume":"179","author":"Bauersachs","year":"2022","journal-title":"Br J Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvaf252","article-title":"Adrenal-adipose tissue crosstalk in health and disease","volume":"193","author":"Jiang","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065370","article-title":"The effect of aldosterone on cardiorenal and metabolic systems","volume":"24","author":"Otsuka","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.06.035","article-title":"Novel mechanisms of salt-sensitive hypertension","volume":"104","author":"Vogt","year":"2023","journal-title":"Kidney Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1055\/a-1116-2407","article-title":"Salt appetite and its effects on cardiovascular risk in primary aldosteronism","volume":"52","author":"Adolf","year":"2020","journal-title":"Horm Metab Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-01045-5","article-title":"Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels","volume":"46","author":"Yoshida","year":"2023","journal-title":"Hypertens Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/bs.vh.2025.10.009","article-title":"Aldosterone & cortisol cosecretion","volume":"130","author":"Candela","year":"2026","journal-title":"Vitam Horm"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-25-0031","article-title":"Connshing syndrome: Complexity of cortisol co-secretion in primary aldosteronism","volume":"2025","author":"Ferreira","year":"2025","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2020.05.005","article-title":"Genetic and genomic mechanisms of primary aldosteronism","volume":"26","author":"Fernandes-Rosa","year":"2020","journal-title":"Trends Mol Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgag002","article-title":"Somatic drivers in aldosterone-producing adenomas and nodules: Insights from a Brazilian cohort of primary aldosteronism","author":"Guimaraes","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.20921","article-title":"Primary aldosteronism: Spatial multiomics mapping of genotype-dependent heterogeneity and tumor expansion of aldosterone-producing adenomas","volume":"80","author":"Gong","year":"2023","journal-title":"Hypertension"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.823065","article-title":"Exploration of kcnj5 somatic mutation and cyp11b1\/cyp11b2 staining in multiple nodules in primary aldosteronism","volume":"9","author":"Xie","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1548344","article-title":"Advances in the biochemical diagnostics of primary aldosteronism: From immunoassays to steroidomics and proteomics","volume":"16","author":"Szatko","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsbmb.2014.10.006","article-title":"An lc-ms\/ms method for steroid profiling during adrenal venous sampling for investigation of primary aldosteronism","volume":"145","author":"Peitzsch","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-oxocortisol synthesis in aldosterone-producing adrenocortical adenoma and significance of kcnj5 mutation status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of steroid profiling combined with machine learning for identification and subtype classification in primary aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11465","article-title":"Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"72","author":"Meyer","year":"2018","journal-title":"Hypertension"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/joim.70055","article-title":"Emerging methods for subtype differentiation in primary aldosteronism","volume":"299","author":"Ragnarsson","year":"2026","journal-title":"J Intern Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf396","article-title":"Approach to the patient with primary aldosteronism: Role of molecular imaging","volume":"110","author":"Teo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"(11)c]metomidate pet-ct versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: A prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00531","article-title":"Kcnj5 somatic mutation is a predictor of hypertension remission after adrenalectomy for unilateral primary aldosteronism","volume":"104","author":"Vilela","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.04.007","article-title":"Cardiovascular outcomes of kcnj5 mutated aldosterone-producing adenoma: A systematic review","volume":"30","author":"Kato","year":"2024","journal-title":"Endocr Pract"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111708","article-title":"Progress on genetic basis of primary aldosteronism","volume":"9","author":"Karwacka","year":"2021","journal-title":"Biomedicines"},{"key":"B68","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial hyperaldosteronism: An european reference network on rare endocrine conditions clinical practice guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/164_2023_660","article-title":"Ca(v)3.2 (cacna1h) in primary aldosteronism","volume":"279","author":"Dinh","year":"2023","journal-title":"Handb Exp Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1005934","article-title":"A new machine learning-based prediction model for subtype diagnosis in primary aldosteronism","volume":"13","author":"Shi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(25)00263-3","article-title":"Post-treatment renin status and cardiovascular, renal, and mortality outcomes in medically treated primary aldosteronism: A systematic review and meta-analysis","volume":"13","author":"Katsuragawa","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-111167","article-title":"Renin-guided therapy with mineralocorticoid receptor antagonists in primary aldosteronism: Feasibility study (retame-pa) - a clinical research protocol for a randomised controlled trial","volume":"15","author":"Merabtine","year":"2025","journal-title":"BMJ Open"},{"key":"B73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1530\/JOE-21-0228","article-title":"Gammaenac\/cd9 in urinary extracellular vesicles as a potential biomarker of mr activity","volume":"252","author":"Hayakawa","year":"2021","journal-title":"J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.124.23379","article-title":"Enacgamma in urinary extracellular vesicles as an indicator of mr signaling in primary aldosteronism","volume":"81","author":"Hayama","year":"2024","journal-title":"Hypertension"},{"key":"B75","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215312","article-title":"Circulating micrornas as diagnostic markers in primary aldosteronism","volume":"13","author":"MacKenzie","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating primary aldosteronism-induced hypertension: Novel approaches and future outlooks","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"key":"B78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1210\/clinem\/dgac568","article-title":"Aldosterone, renin, and aldosterone-to-renin ratio variability in screening for primary aldosteronism","volume":"108","author":"Ng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab290","article-title":"Mineralocorticoid receptor antagonist effect on aldosterone to renin ratio in patients with primary aldosteronism","volume":"106","author":"Pecori","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae039","article-title":"Health care challenges in the management of primary aldosteronism in southeast asia","volume":"109","author":"Sukor","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf663","article-title":"Implementation of a spanish-language, direct-to-patient primary aldosteronism testing program","volume":"111","author":"Ferrebus","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvaf185","article-title":"Preferences for subtyping primary aldosteronism: A discrete choice experiment","volume":"10","author":"Woode","year":"2026","journal-title":"J Endocr Soc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1842927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:22:31Z","timestamp":1779164551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1842927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":82,"alternative-id":["10.3389\/fendo.2026.1842927"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1842927","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1842927"}}